Literature DB >> 8789658

Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.

H Kolles1, I Niedermayer, C Schmitt, W Henn, R Feld, W I Steudel, K D Zang, W Feiden.   

Abstract

With regard to meningioma grading and the recently introduced "atypical" meningioma, we evaluated 160 cases retrospectively by conventional histology and image analysis. For that, the cell nuclei were stained with a Ki-67 (MIB1)/Feulgen-method on paraffin sections, thus enabling the assessment of both the Ki-67 proliferation index and nuclear morphometric features, such as tumour cell arrangement, nuclear pleomorphism, and cellularity. It could be demonstrated that the Ki-67 proliferation index is the most important criterion for distinguishing anaplastic meningiomas (WHO "grade" III) (mean Ki-67 index: 11%) from those of common type (WHO "grade" I) (mean Ki-67 index: 0.7%). The parameter for the "relative volume weighted mean nuclear volume" is another valuable morphometric feature. The "atypical" meningioma (WHO "grade" II) which should represent an intermediate category between common type and anaplastic meningiomas is characterized by a mean Ki-67 proliferation index of 2.1%. Common type meningiomas which comprise almost 50% of the cases of this series have a relapse rate of 9%. "Atypical" and anaplastic meningiomas recurred in 29% and 50%, respectively. Since the term "atypical" meningioma is confusing in the context of tumour grading, the term "intermediate type meningioma" is proposed. Furthermore, the results of cytogenetic analyses of 142 cases of this series were evaluated and compared with the meningioma grades. Thereby, 25 cases disclosed, independent of the typical loss of one chromosome 22, cytogenetic features assumed to be progression-associated, e.g., the gain or loss of different chromosomes and the deletion of the short arm of one chromosome 1 (hyperdiploidy, increased hypodiploidy, 1p-), when correlated to the histological and morphometric findings or the high relapse rate. For meningioma diagnosis and grading, a practical guideline is proposed based upon histology, morphometry (Ki-67), and cytogenetics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8789658     DOI: 10.1007/bf02187190

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  41 in total

1.  Prediction of biologic aggressiveness in human meningiomas: a cell kinetic study using bromodeoxy-uridine in cells of primary explant culture.

Authors:  K Kharbanda; A K Karak; C Sarkar; A K Dinda; M Mathur; S Roy
Journal:  J Natl Cancer Inst       Date:  1992-02-05       Impact factor: 13.506

2.  Will chromosome karyotyping of meningiomas aid prediction of tumour recurrence?

Authors:  R Strachan; C Clarke; M Nurbhai; S Marks
Journal:  Br J Neurosurg       Date:  1989       Impact factor: 1.596

3.  Meningiomas: clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling.

Authors:  M Shibuya; T Hoshino; S Ito; M R Wacker; M D Prados; R L Davis; C B Wilson
Journal:  Neurosurgery       Date:  1992-04       Impact factor: 4.654

4.  Histological subtypes and prognostic problems in meningiomas.

Authors:  K Jellinger; F Slowik
Journal:  J Neurol       Date:  1975       Impact factor: 4.849

5.  Chromosomal consitution of meningiomas.

Authors:  K D Zang; H Singer
Journal:  Nature       Date:  1967-10-07       Impact factor: 49.962

6.  Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance.

Authors:  H Maier; D Ofner; A Hittmair; K Kitz; H Budka
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

7.  Combined Ki-67 and Feulgen stain for morphometric determination of the Ki-67 labelling index.

Authors:  H Kolles; W Förderer; R Bock; W Feiden
Journal:  Histochemistry       Date:  1993-10

8.  Stereological estimation of nuclear volume in benign and atypical meningiomas.

Authors:  C Madsen; H D Schrøder
Journal:  APMIS       Date:  1993-01       Impact factor: 3.205

9.  The prediction of recurrence in meningiomas. A flow cytometric study of paraffin-embedded archival material.

Authors:  P L May; J C Broome; J Lawry; R A Buxton; R D Battersby
Journal:  J Neurosurg       Date:  1989-09       Impact factor: 5.115

10.  Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.

Authors:  C Zimmer; J Gottschalk; J Cervos-Navarro; H Martin; M Beil; G Jautzke
Journal:  Pathol Res Pract       Date:  1992-12       Impact factor: 3.250

View more
  22 in total

1.  An unusual intraventricular haemangiopericytoma: MRI and spectroscopy.

Authors:  E Hattingen; U Pilatus; C Good; K Franz; H Lanfermann; F E Zanella
Journal:  Neuroradiology       Date:  2003-04-18       Impact factor: 2.804

2.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

3.  Hyperdiploidy defines a distinct cytogenetic entity of meningiomas.

Authors:  Ralf Ketter; Yoo-Jin Kim; Simone Storck; Jörg Rahnenführer; Bernd F M Romeike; Wolf-Ingo Steudel; Klaus D Zang; Wolfram Henn
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

4.  Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters.

Authors:  Yoo-Jin Kim; Ralf Ketter; Wolfram Henn; Klaus D Zang; Wolf-Ingo Steudel; Wolfgang Feiden
Journal:  Virchows Arch       Date:  2006-10-03       Impact factor: 4.064

5.  Prognostic significance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas.

Authors:  Y Kamei; M Watanabe; T Nakayama; K Kanamaru; S Waga; T Shiraishi
Journal:  J Neurooncol       Date:  2000       Impact factor: 4.130

6.  Are Osteopontin and Ki67 Expressions Different in Various Histologic Grades of Meningioma? An Iranian Experience.

Authors:  Forough Hashemi; Pegah Babaheidarian; Soheila Dabiran
Journal:  Iran J Pathol       Date:  2015

7.  Histopathological and Immunohistochemical Evaluation of Meningiomas with Reference to Proliferative Markers p53 and Ki-67.

Authors:  Ramesh Babu Telugu; Amit Kumar Chowhan; Nandyala Rukmangadha; Rashmi Patnayak; Bobbidi Venkata Phaneendra; Bodapati Chandra Mowliswara Prasad; Mandyam Kumaraswamy Reddy
Journal:  J Clin Diagn Res       Date:  2016-01-01

8.  The influence of age on the histological grading of meningiomas.

Authors:  Jae-Sung Park; Burak Sade; Soichi Oya; Chong Gue Kim; Joung H Lee
Journal:  Neurosurg Rev       Date:  2014-04-29       Impact factor: 3.042

9.  Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.

Authors:  Stanley Yang; Meng Law; David Zagzag; Hope H Wu; Soonmee Cha; John G Golfinos; Edmond A Knopp; Glyn Johnson
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

Review 10.  A report of primary brain fibrosarcoma with literature review.

Authors:  Ning Cai; Leonard B Kahn
Journal:  J Neurooncol       Date:  2004-06       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.